Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00911703 · ClinicalTrials.gov registry record
Determining When Patients Hospitalized With Acute Heart Failure Can Be Safely Sent Home (The DECIDE Study)
A clinical trial of Acute Heart Failure, sponsored by Vanderbilt University.
- Completed
- Registry status
- 835
- Enrollment target
- 2
- Study locations
NCT00911703: Completed study of Acute Heart Failure, sponsored by Vanderbilt University.
NCT00911703 is a study of Acute Heart Failure that has completed, run by Vanderbilt University. The registered enrollment target is 835 participants, below the 1,348-participant average among 8 other Acute Heart Failure trials with a reported enrollment target (38% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00911703, a study of Acute Heart Failure, has completed, sponsored by Vanderbilt University.
- COMPLETED
- Registry status
- 835 participants
- Enrollment target
- 2
- Study locations
Study Summary
The purpose of this study is to determine if certain findings (blood tests, symptom improvement, etc.) after acute heart failure treatment can identify a group of patients who are safe for early hospital discharge.
Conditions Studied
Study Locations (2)
Ohio
- University of Cincinnati - Cincinnati
Tennessee
- Vanderbilt University - Nashville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 835 participants |
| Start Date | 2008-08 |
| Est. Completion | 2015-10 |
What the finished NCT00911703 record still lists
NCT00911703 is an observational study that tracks outcomes without assigning an intervention. The registered 835 participants enrollment target is mid-sized for trials with a published cap, below the 1,348-participant average among 8 other Acute Heart Failure trials with a reported enrollment target (38% lower).
The record links to 1 condition, with Acute Heart Failure appearing as the primary indexed condition, and to 0 interventions.
NCT00911703 reports a single indexed study location in Ohio, Tennessee.
Frequently Asked Questions
What is clinical trial NCT00911703 about?
NCT00911703 is a clinical study titled "Determining When Patients Hospitalized With Acute Heart Failure Can Be Safely Sent Home (The DECIDE Study)". The purpose of this study is to determine if certain findings (blood tests, symptom improvement, etc.) after acute heart failure treatment can identify a group of patients who are safe for early hospital discharge.
What is the current status of trial NCT00911703?
This trial is currently completed. The enrollment target is 835 participants. The study started on 2008-08. Estimated completion is 2015-10.
What conditions does trial NCT00911703 study?
This clinical trial studies the following conditions: Acute Heart Failure.
Who is sponsoring clinical trial NCT00911703?
This trial is sponsored by Vanderbilt University, which has 430 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00911703 being conducted?
This trial has 2 study locations across Ohio, Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Acute Heart Failure
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00911703's enrollment target sits among peer trials
835 4th of 8 higher than 5 of 8 other Acute Heart Failure trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Acute Heart Failure trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure Patients
RECRUITING · Phase 3
-
Improving Diagnostic Accuracy for Acute Heart Failure
ACTIVE NOT RECRUITING
-
Randomized Controlled Trial of urinE chemiStry Guided aCute heArt faiLure treATmEnt (ESCALATE)
ACTIVE NOT RECRUITING · Phase 2
-
Subcutaneous Furosemide in Acute Decompensated Heart Failure Pilot
COMPLETED · Phase 1
-
An Observational Study of the Functional Capacity of Heart Failure
COMPLETED · NA
-
Tezosentan in Acute Heart Failure
COMPLETED · Phase 3
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03670524 · 835 participants · NA
Health, Environment and Action in Louisville (HEAL) Green Heart Louisville Project
- NCT02118467 · 836 participants · Phase 4
Vasoactive Drugs in Intensive Care Unit
- NCT02422550 · 837 participants
Imaging Acquisition and Analysis Methods for Optimization of MRI Radiation Oncology Simulation and Response Assessment
- NCT06910553 · 832 participants
IBD Pregnancy Registry
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia